Global Vaccines Market is valued at USD 45.9 Billion in 2019 and expected to reach USD 91.9 Billion by 2026 with the CAGR of 10.44 % over the forecast period. Progress has already been made with several therapeutic vaccines for cancer, diabetes, hypertension and Alzheimer's disease. According to the WHO (World Health Organization) in 2019 were more than 240 vaccines in development for 25 infectious diseases. HIV/AIDS, malaria, pneumococcal infections, tuberculosis, and Ebola vaccine are the major diseases leading the way. Increasing company initiatives to enhance vaccine R&D, growing prevalence of infectious diseases and exploding population growth are the major drivers for the growth of global vaccine market. In addition to this spread of novel coronavirus around the world has resulted into fast track vaccine development to control the disease. There are 321 candidates in coronavirus vaccine development as of October 2020. Out of which 44 vaccine candidates were conducting clinical trials 34 in Phase I–II t
